Steqeyma 130mg / 26mL, solution à diluer pour perfusion

7680700020015 CH-70002 Lösung
Steqeyma 130mg / 26mL, solution à diluer pour perfusion
Steqeyma 130mg / 26mL, solution à diluer pour perfusion
Steqeyma 130mg / 26mL, solution à diluer pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/10/2026
Summary of Product Characteristics
Français
06/10/2026
Summary of Product Characteristics
Italien
06/10/2026

Detailed composition

Substance Quantity Type Category
ustekinumabum
130.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HIMDK
histidini hydrochloridum monohydricum
- Substance HIMDK
dinatrii edetas
- Substance HNIDK
methioninum
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.06 MG Substance HBESI

Reimbursement information

Public price
CHF 1540.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2026

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
70002
Drug name
Steqeyma, solution à diluer pour perfusion
Galenic form
KOINF
ATC Code
L04AC05
Authorization status
Z
Dispensing category
B
First authorization
24/04/2025
Authorization expiration date
23/04/2030
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
STEQEYMA 130mg / 26mL conc perf 130 mg 1 pce
Description (DE)
STEQEYMA 130mg / 26mL Konz Inf 130 mg 1 Stk
Market launch
01/05/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data